Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 27, 2025Journal of the Egyptian National Cancer InstituteOpen Access

Unraveling LncRNAs: the future of lung cancer treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

ZJZahraa Isam JameelHCHalla Abdul-Hadi Chabuk

Discussion

Loading...

Member takes

Overview

Review highlights the role of long non-coding RNAs in lung cancer, suggesting they may serve as diagnostic tools and novel treatment strategies.

Key Points

  • Long non-coding ribonucleic acids are crucial in lung cancer, impacting its progression and treatment.
  • Research shows their potential as non-invasive diagnostic tools and indicators of patient outcomes.
  • Assessment of their oncogenic and tumor-suppressing roles may lead to innovative treatment strategies.
  • Understanding biological functions of LncRNAs could unveil new therapeutic pathways for lung cancer patients.

Cite This Study

Jameel et al. (2025) studied this question.

synapsesocial.com/papers/68ff87e2c8c50a61f2bdcff7https://doi.org/10.1186/s43046-025-00327-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Research progress on long non‑coding RNAs in lung cancer (Review)2026
  2. 2The role of long non‐coding RNAs in lung cancer metastasis: Molecular mechanisms, pathogenesis and clinical implications2025 · 10 citations
  3. 3Advances in Research on the Role of Long Non-Coding RNAs in Lung Cancer Diagnosis, Treatment, and Drug Resistance2026
  4. 4Exploring the enigma: history, present, and future of long non-coding RNAs in cancer2024 · 17 citations
  5. 5LncRNAs: key regulators and molecular mechanisms in lung cancer radiosensitivity2026